Erin Mulvey, M.D.


Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

At Weill Cornell Medicine, I am part of a world-renowned, multidisciplinary team of physicians and scientists who are dedicated to caring for patients with lymphoma. We are able to offer cutting-edge diagnostic testing and novel therapies to our patients. I have had the opportunity to train with some of the leading experts in cancer research and am confident that scientific advancements will continue to drive progress in the treatment of lymphoma, ultimately allowing our patients to feel better and live longer. 

I don’t believe in a “one-size fits all” approach when treating cancer, as every patient is unique.  I am committed to developing individualized treatment plans in collaboration with each of my patients, optimized to meet their particular circumstances while utilizing the most innovative treatments available to date. I know how overwhelming a cancer diagnosis is, and I prioritize taking my time to answer any and all questions clearly and honestly. 

Biographical Info

Dr. Erin Mulvey is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine. She competed her undergraduate education at Boston University where she earned a degree in Biochemistry and Molecular Biology. She received her medical degree from New York Medical College. Dr. Mulvey completed both her Residency in Internal Medicine and her Fellowship in Hematology/Oncology at NewYork-Presbyterian Hospital and Weill Cornell Medical College.  

Upon completion of her training, Dr. Mulvey joined the Weill Cornell Lymphoma Program where she specializes in treating patients with lymphoma and is an active investigator in several clinical trials. Her research is centered on B cell lymphomas, including indolent lymphomas such as follicular lymphoma as well as aggressive forms such as diffuse large B-cell lymphoma. Dr. Mulvey is focused on the study and manipulation of the interaction between the body’s own immune system and cancerous cells. She also has a special interest in patient reported outcomes in clinical trials, and has received honors from the Lymphoma Research Foundation (LRF). 

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Medical Oncology)
Clinical Expertise
DLBCL (Diffuse Large B Cell Lymphoma)
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Non-Hodgkin Lymphoma
CLL (Chronic Lymphocytic Leukemia)
Chronic Lymphocytic Leukemia
  • M.D.
    New York Medical College
  • B.A.
    Boston University
  • Assistant Attending Physician
    NewYork-Presbyterian Hospital
  • Assistant Professor of Medicine
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Advisory/Scientific Board Member: 
Other Interest: 
Lymphoma Research Foundation